Glenmark Pharma reports consolidated revenue growth of 6.3 per cent and adjusted EBITDA growth of 8.3 per cent YoY for Q2 FY 2023-24
Nov 11, 2023
Mumbai (Maharashtra) [India], November 11: Glenmark Pharmaceuticals Ltd. (Glenmark), a research led, global pharmaceutical company, today announced its financial results for the second quarter...